NCT07031323NARecruiting

OnTrackCF: Engagement, Feasibility, and Acceptability Study

Boston Children's Hospital

Start Date

11/20/2025

Completion Date

12/1/2026

Summary

This is a multi-site, nonrandomized study using mixed methods approach to evaluate the feasibility, acceptability, and user engagement of OnTrackCF for adults with Cystic Fibrosis (AWCF).

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: 1. Diagnosed with CF 2. 18+ years of age 3. Prescribed a CFTR modulator therapy to be taken twice a day 4. Can speak and read English 5. Have regular access to an iOS or Android tablet or smartphone with internet access. Exclusion Criteria: 1\) Any situation, in the opinion of the Investigator, that would compromise the safety of the patient or the quality of the data

Interventions

BEHAVIORAL

OnTrackCF

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Cystic Fibrosis (CF)Cystic Fibrosis - Complete

Locations

University of Alabama-Birmingham

Birmingham, Alabama 35233

United States

Johns Hopkins University

Baltimore, Maryland 21218

United States

Boston Children's Hospital

Boston, Massachusetts 02115

United States

Run studies, or work at a research site?

Corterve helps sites and sponsors reach patients who are looking for trials. It does not determine eligibility and does not promise an enrolment outcome.

For sponsors, CROs and sites

What Corterve sells to organisations, and the anti-kickback constraints it works within.

Services and published prices

Lay summaries for EU CTR Annex V, pre-screen filtration, recruitment-creative regulatory operations, feasibility reporting.

For research sites

One published licence rate, the same for every site, and the fees a site is never charged.